155 related articles for article (PubMed ID: 38072720)
21. Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism.
Arasaratnam CJ; Singh-Bains MK; Waldvogel HJ; Faull RLM
Neurobiol Dis; 2021 Jan; 148():105186. PubMed ID: 33227492
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.
Pozojevic J; Algodon SM; Cruz JN; Trinh J; Brüggemann N; Laß J; Grütz K; Schaake S; Tse R; Yumiceba V; Kruse N; Schulz K; Sreenivasan VKA; Rosales RL; Jamora RDG; Diesta CCE; Matschke J; Glatzel M; Seibler P; Händler K; Rakovic A; Kirchner H; Spielmann M; Kaiser FJ; Klein C; Westenberger A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216353
[TBL] [Abstract][Full Text] [Related]
23. Phenomenology of "Lubag" or X-linked dystonia-parkinsonism.
Evidente VG; Advincula J; Esteban R; Pasco P; Alfon JA; Natividad FF; Cuanang J; Luis AS; Gwinn-Hardy K; Hardy J; Hernandez D; Singleton A
Mov Disord; 2002 Nov; 17(6):1271-7. PubMed ID: 12465067
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat.
Campion LN; Mejia Maza A; Yadav R; Penney EB; Murcar MG; Correia K; Gillis T; Fernandez-Cerado C; Velasco-Andrada MS; Legarda GP; Ganza-Bautista NG; Lagarde JBB; Acuña PJ; Multhaupt-Buell T; Aldykiewicz G; Supnet ML; De Guzman JK; Go C; Sharma N; Munoz EL; Ang MC; Diesta CCE; Bragg DC; Ozelius LJ; Wheeler VC
Acta Neuropathol Commun; 2022 Apr; 10(1):49. PubMed ID: 35395816
[TBL] [Abstract][Full Text] [Related]
25. Differential response of dystonia and parkinsonism following globus pallidus internus deep brain stimulation in X-linked dystonia-parkinsonism (Lubag).
Oyama G; Fernandez HH; Foote KD; Zeilman P; Hwynn N; Jacobson CE; Malaty IA; Rodriguez RL; Okun MS
Stereotact Funct Neurosurg; 2010; 88(5):329-33. PubMed ID: 20714213
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
[TBL] [Abstract][Full Text] [Related]
27. First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia.
Plummer C; Bradfield J; Singleton AB; Hernandez D; Singleton AA; O'sullivan J
J Clin Neurosci; 2005 Nov; 12(8):945-6. PubMed ID: 16242937
[TBL] [Abstract][Full Text] [Related]
28. Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP).
Mertin R; Diesta C; Brüggemann N; Rosales RL; Hanssen H; Westenberger A; Steinhardt J; Heldmann M; Manalo HTS; Oropilla JQ; Klein C; Helmchen C; Sprenger A
J Neurol; 2023 Sep; 270(9):4262-4275. PubMed ID: 37191726
[TBL] [Abstract][Full Text] [Related]
29. Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.
Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Aguil A; Ganza-Bautista NG; Lagarde JBB; Soria J; Jamora RDG; Acuña PJ; Vanderburg C; Sapp E; DiFiglia M; Murcar MG; Campion L; Ozelius LJ; Alessi AK; Singh-Bains MK; Waldvogel HJ; Faull RLM; Macalintal-Canlas R; Muñoz EL; Penney EB; Ang MA; Diesta CCE; Bragg DC; Acuña-Sunshine G
J Neural Transm (Vienna); 2021 Apr; 128(4):575-587. PubMed ID: 33439365
[TBL] [Abstract][Full Text] [Related]
30. X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.
Rosales RL
J Mov Disord; 2010 Oct; 3(2):32-8. PubMed ID: 24868378
[TBL] [Abstract][Full Text] [Related]
31. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias.
Rosales RL; Santos MM; Ng AR; Teleg R; Dantes M; Lee LV; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():35-43. PubMed ID: 21244305
[TBL] [Abstract][Full Text] [Related]
32. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
Rosales RL; Ng AR; Santos MM; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
[TBL] [Abstract][Full Text] [Related]
33. Cost-Analysis of the Different Treatment Modalities in X-Linked Dystonia-Parkinsonism.
De Roxas RC; Jamora RDG
Front Neurol; 2019; 10():500. PubMed ID: 31143158
[No Abstract] [Full Text] [Related]
34. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).
Kawarai T; Morigaki R; Kaji R; Goto S
Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28672841
[TBL] [Abstract][Full Text] [Related]
35. First case of X-linked dystonia-parkinsonism ("Lubag") to demonstrate a response to bilateral pallidal stimulation.
Evidente VG; Lyons MK; Wheeler M; Hillman R; Helepolelei L; Beynen F; Nolte D; Müller U; Starr PA
Mov Disord; 2007 Sep; 22(12):1790-3. PubMed ID: 17579361
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and molecular analyses of X-linked dystonia-parkinsonism ("lubag") in women.
Evidente VG; Nolte D; Niemann S; Advincula J; Mayo MC; Natividad FF; Müller U
Arch Neurol; 2004 Dec; 61(12):1956-9. PubMed ID: 15596620
[TBL] [Abstract][Full Text] [Related]
37. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.
Aneichyk T; Hendriks WT; Yadav R; Shin D; Gao D; Vaine CA; Collins RL; Domingo A; Currall B; Stortchevoi A; Multhaupt-Buell T; Penney EB; Cruz L; Dhakal J; Brand H; Hanscom C; Antolik C; Dy M; Ragavendran A; Underwood J; Cantsilieris S; Munson KM; Eichler EE; Acuña P; Go C; Jamora RDG; Rosales RL; Church DM; Williams SR; Garcia S; Klein C; Müller U; Wilhelmsen KC; Timmers HTM; Sapir Y; Wainger BJ; Henderson D; Ito N; Weisenfeld N; Jaffe D; Sharma N; Breakefield XO; Ozelius LJ; Bragg DC; Talkowski ME
Cell; 2018 Feb; 172(5):897-909.e21. PubMed ID: 29474918
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Glucocorticoids on
Cruz SED; Bagamasbad P
J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
[TBL] [Abstract][Full Text] [Related]
39. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
Vaine CA; Shin D; Liu C; Hendriks WT; Dhakal J; Shin K; Sharma N; Bragg DC
Neurobiol Dis; 2017 Apr; 100():108-118. PubMed ID: 28017799
[TBL] [Abstract][Full Text] [Related]
40. SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
Petrozziello T; Dios AM; Mueller KA; Vaine CA; Hendriks WT; Glajch KE; Mills AN; Mangkalaphiban K; Penney EB; Ito N; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña G; Sharma N; Ozelius LJ; Bragg DC; Sadri-Vakili G
PLoS One; 2020; 15(12):e0243655. PubMed ID: 33315879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
